SERPINB5 and ovarian carcinoma: Sood et al [36] demonstrated that mixed nuclear and cytoplasmic maspin localization in ovarian cancer is indicative of a more benign lesion than neoplasms with cytoplasmic expression only, suggesting an important tumor-suppressive role for nuclear maspin.